Profile image
Story Views

Last Hour:
Last 24 Hours:

Visceral Pain – Pipeline Review, H1 2017

Monday, March 20, 2017 2:39
% of readers think this story is Fact. Add your two cents.

(Before It's News)


Ethocle Reports has published its latest Market Research Report on Visceral Pain – Pipeline Review, H1 2017. The Visceral Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects. Browse market data tables and figures.


                                                                                                                    Published On: 15-Mar-2017 | Pages: 56


Pharmaceutical and Healthcare disease pipeline guide Visceral Pain – Pipeline Review, H1 2017, provides an overview of the Visceral Pain (Central Nervous System) pipeline landscape.

Visceral pain is a type of nociceptive pain that comes from the internal organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pain modifiers such as tricyclic antidepressants or anticonvulsants.

Capture.PNG     d.PNG     dd.PNG

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Visceral Pain – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Visceral Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


- The pipeline guide provides a snapshot of the global therapeutic landscape of Visceral Pain (Central Nervous System).

- The pipeline guide reviews pipeline therapeutics for Visceral Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Visceral Pain (Central Nervous System).

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents


Global Markets Direct Report Coverage

Visceral Pain – Overview

Pipeline Overview

Products under Development by Companies

Products under Development by Universities/Institutes

Visceral Pain – Therapeutics Assessment

Assessment by Molecule Type

Eli Lilly and Company

GIcare Pharma Inc

Grunenthal GmbH

Medestea Research & Production SpA

Neurim Pharmaceuticals Ltd

Pfizer Inc

Visceral Pain – Drug Profiles

ADX-71441 – Drug Profile

Product Description

Mechanism Of Action


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.